ValiRx receives EU patent grant for prostate cancer drug

ValiRx receives EU patent grant for prostate cancer drug

() said it has received a patent grant from the EU patent and trademark office for its VAL201 prostate cancer treatment that is currently in clinical trials. The AIM-listed pharmaceuticals company said the patent grant represented another major milestone in its commercial strategy, with the VAL201 portfolio having received patents in the US, […]

Genentech Asks Fed. Circ. To Save Its Breast Cancer Drug Win

Genentech Asks Fed. Circ. To Save Its Breast Cancer Drug Win

By Kevin Penton Law360 (April 24, 2018, 8:42 PM EDT) — Genentech on Monday urged the Federal Circuit to affirm a California federal judge’s tossing of claims that it induced others to infringe a patent covering treatments for conditions such as breast cancer, arguing that not only was the lower court correct to do so, […]

Eli Lilly's profit beats on strong sales of diabetes, cancer drugs

Eli Lilly's profit beats on strong sales of diabetes, cancer drugs

(Reuters) – Eli Lilly and Co (LLY.N) lifted its full-year profit forecast on Tuesday after comfortably beating estimates for the first quarter, largely due to strong sales of its diabetes and cancer drugs and lower expenses. FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of […]

FDA slaps partial hold on Epizyme's lead drug; analysts say 'don't panic'

FDA slaps partial hold on Epizyme's lead drug; analysts say 'don't panic'

Shares in Epizyme slipped in premarket trading today after the company announced a suspension of patient recruitment in a trial of its lead cancer drug after a patient developed a secondary lymphoma, but analysts at Jefferies are expecting the stock to bounce back. The company says the FDA has implemented a partial clinical hold on […]

Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer

Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer

Xconomy San Francisco —  Revolution Medicines emerged three years ago to develop drugs from products found in nature and said its lead prospect would be an antifungal compound. Redwood City, CA-based Revolution is now focused on cancer and has raised $56 million to bring a completely different drug into clinical studies. The firm is targeting […]

Government set to subsidise two $5000 per month breast cancer drugs

Government set to subsidise two $5000 per month breast cancer drugs

Women fighting breast cancer will no longer face treatment bills in the tens of thousands of dollars after two drugs were preliminarily listed on the Pharmaceutical Benefits Scheme (PBS), all but paving the way for their full subsidisation. On Friday,  Palbociclib and Ribociclib, two tablet-form inhibitors prescribed to patients suffering metastatic breast cancer, were recommended for […]